took Solian for several months after persistent suspiciousness and disrupted sleep. He said the first week brought daytime tiredness, but his sleep became more regular and the intrusive thoughts gradually eased. He later needed a dose review because restlessness made desk work difficult.
Several months 19 Nov 2026
Solian
Solian tablets are taken by mouth, with timing and food instructions set by the prescribed regimen. They contain amisulpride and are used in adults for schizophrenia, helping reduce psychotic…
Solian tablets are taken by mouth, with timing and food instructions set by the prescribed regimen. They contain amisulpride and are used in adults for schizophrenia, helping reduce psychotic symptoms through selective dopamine-receptor activity in the brain.
Product information
Solian contains amisulpride, a substituted benzamide antipsychotic used in the management of schizophrenia. The French National Agency for Medicines and Health Products Safety describes amisulpride as a dopamine D2 and D3 receptor antagonist used in schizophrenia care.[1]
Ingredients
Solian contains amisulpride, a substituted benzamide antipsychotic used in the management of schizophrenia.
Therapeutic indications
Solian contains amisulpride, a substituted benzamide antipsychotic used in the management of schizophrenia. It may be prescribed for positive symptoms such as hallucinations, delusions, agitation, and disorganised thinking, as well as selected negative symptoms such as social withdrawal and reduced emotional expression. Treatment decisions depend on the person’s symptoms, medical history, age, kidney function, and response to therapy.
Solian is mainly used for schizophrenia and related psychotic disorders when an antipsychotic is clinically appropriate. It does not treat ordinary stress, uncomplicated insomnia, or temporary sadness. The treatment goal is usually symptom control, relapse prevention, and improved daily functioning.
Directions for use
Solian tablets are taken orally. The dose differs between strengths and between users, so there is no single amount that suits everyone. A psychiatrist usually starts with a regimen matched to the dominant symptoms and adjusts it according to clinical response and tolerability.
Oral administration and dosage guidelines
Solian is taken by mouth with water. The exact dose, frequency, and duration are prescribed for the individual. Some regimens use a single daily dose, while others divide the daily amount into two administrations.
Follow these practical steps:
- Take the prescribed amount at the scheduled time.
- Keep the timing consistent from day to day.
- Follow the food instructions supplied with the prescription, because meal timing can affect exposure for some tablet regimens.
- Swallow the tablet whole unless splitting has been specifically authorised.
- Do not double the next dose after a missed dose.
- If a missed dose is remembered close to the next scheduled dose, skip the forgotten dose and resume the normal schedule.
- Seek urgent advice if several doses have been missed or symptoms begin returning.
Alcohol can increase drowsiness, dizziness, impaired coordination, and difficulty thinking clearly. Combining alcohol with Solian is therefore an avoidable risk, especially during treatment initiation or after a dose change.
Sudden discontinuation can cause insomnia, nausea, restlessness, sweating, anxiety, and a return of psychotic symptoms. The World Health Organization supports careful continuity of treatment for schizophrenia, with changes made through a planned clinical approach rather than abrupt stopping.[3]
When not to use it
Solian is not appropriate for everyone. The following situations require specific medical review before treatment:
- Known allergy to amisulpride or an excipient in the tablet.
- Previous serious reaction to amisulpride.
- Prolactin-dependent breast cancer or a history requiring specialist assessment.
- Phaeochromocytoma.
- Congenital long-QT syndrome or a significant history of serious cardiac rhythm disturbance.
- Severe kidney impairment, because amisulpride is cleared largely through the kidneys.
- Previous neuroleptic malignant syndrome.
- Parkinson’s disease or Lewy body dementia, where dopamine blockade may worsen movement and cognitive symptoms.
- Pregnancy or breastfeeding, where benefits and neonatal risks require assessment.
- A history of seizures or conditions that lower the seizure threshold.
Avoid combining Solian with medicines that can cause serious QT prolongation unless a prescriber has assessed the combination. Examples include some antiarrhythmics, selected antibiotics, certain antidepressants, and other antipsychotics. Levodopa and dopamine agonists can oppose the action of amisulpride, while other sedating medicines can worsen drowsiness and impaired coordination.
Kidney function matters. Reduced clearance can raise amisulpride exposure, so people with kidney disease may require a different regimen or closer monitoring. Older adults are more vulnerable to falls, low blood pressure, confusion, movement effects, and cardiac complications.
When this is not for you
NOT for you if you have an untreated condition that could make dopamine blockade, QT prolongation, or reduced kidney clearance unsafe; seek an individual medical assessment instead.
Unwanted effects
Amisulpride can cause adverse effects affecting the nervous system, hormones, heart rhythm, digestion, and general alertness. Some effects appear early and improve as the body adjusts. Others require a dose review or a change in treatment.
Common or clinically recognised effects include:
- Restlessness or an inner need to keep moving.
- Tremor, stiffness, slowed movement, or muscle discomfort.
- Sleepiness, dizziness, or reduced concentration.
- Anxiety, agitation, or insomnia.
- Constipation, nausea, or dry mouth.
- Raised prolactin.
- Breast tenderness, breast enlargement, milk production, reduced libido, or menstrual changes.
- Weight change.
- Blurred vision or postural dizziness.
Extrapyramidal symptoms describe drug-related movement problems. Akathisia feels like an inability to sit still and can be mistaken for worsening anxiety. Parkinsonian effects may include stiffness, tremor, reduced facial expression, and smaller steps. Reporting the timing of these symptoms helps the prescriber distinguish a dose-related effect from progression of the underlying illness.
A prolonged QT interval is a change in the heart’s electrical recovery time. It can increase the risk of a serious rhythm disturbance in susceptible people. Risk rises with low potassium or magnesium, congenital long-QT syndrome, significant heart disease, kidney impairment, and combinations with other QT-prolonging medicines.
Rare but urgent reactions include high fever with severe stiffness or confusion, fainting, seizures, uncontrolled movements, severe allergic symptoms, and signs of a dangerous heart rhythm. New involuntary movements around the mouth or tongue also need prompt assessment because tardive dyskinesia can persist after treatment changes.
Weight tracking is useful even when appetite has not changed. Prolactin-related effects can occur without obvious symptoms, so persistent sexual dysfunction, menstrual disruption, breast changes, or milk production should be reported.
Mechanism of action
Amisulpride blocks dopamine D2 and D3 receptors. Its effect is strongest in limbic and striatal brain pathways involved in motivation, perception, movement, and emotional processing. Excess dopamine signalling in some pathways is associated with psychotic symptoms, so reducing that signalling can lessen hallucinations, delusions, and thought disturbance.
The drug can also influence dopamine pathways linked with prolactin release. This explains why breast tenderness, menstrual changes, sexual dysfunction, or milk production can occur in some patients. Amisulpride has limited activity at several other receptor systems compared with some older antipsychotics, yet it can still cause movement symptoms, sedation, dizziness, and cardiac rhythm changes.
Australian prescribing decisions still require individual assessment because antipsychotic treatment can involve important neurological, hormonal, metabolic, and cardiovascular risks.[2]
Common mistakes
Several practical errors can reduce treatment stability:
- Stopping Solian as soon as hallucinations or suspiciousness improve.
- Taking an extra tablet after a missed dose.
- Splitting a tablet without confirming that the prescribed strength supports this.
- Crushing tablets to make swallowing easier without checking suitability.
- Drinking alcohol to counter daytime anxiety or sedation.
- Failing to report sexual dysfunction, menstrual changes, breast symptoms, or milk production.
- Treating new restlessness as proof that the illness is worsening.
- Starting another medicine without checking QT, sedation, or dopamine-related interactions.
- Driving before knowing how the medicine affects alertness and coordination.
- Forgetting to mention kidney disease, fainting episodes, or a family history of sudden cardiac death.
One detail patients often overlook is the difference between akathisia and anxiety. Both can feel uncomfortable, but akathisia usually creates a strong urge to move, pace, or shift position repeatedly. Describing that physical urge can lead to a faster and more accurate medication review.
Comparison
Solian belongs to a group of antipsychotics with a pharmacological profile that differs from medicines acting strongly on serotonin and dopamine receptors together. The choice depends on the symptom pattern, previous treatment response, physical health, and adverse-effect priorities.
| Treatment approach | Main pharmacological focus | Common clinical trade-off |
|---|---|---|
| Amisulpride | Selective dopamine D2/D3 blockade | Prolactin elevation, movement symptoms, and QT prolongation require attention |
| Serotonin-dopamine antipsychotic approach | Dopamine plus serotonin receptor activity | Some options carry greater appetite, weight, glucose, or lipid concerns |
| Long-acting injectable antipsychotic approach | Sustained medicine delivery | Reduces daily tablet decisions but requires scheduled clinical administration |
This comparison describes categories rather than interchangeable treatments. A psychiatrist may favour amisulpride when its dopamine-focused profile fits the person’s previous response and adverse-effect history. Another treatment may be preferred when prolactin elevation, heart-rhythm risk, kidney impairment, or movement symptoms create a concern.
Solian should not be switched with another antipsychotic at an equivalent-looking dose. Conversion schedules differ because receptor activity, half-life, formulation, and withdrawal risks are not identical.
What doctors say
In clinical practice, psychiatrists often judge Solian by more than symptom disappearance. They assess sleep, agitation, suspiciousness, hallucinations, daily structure, social contact, concentration, and the person’s ability to manage routine activities.
A useful response may develop gradually. Early sedation or reduced agitation does not prove that the long-term treatment goal has been reached. The clinician may need several appointments to balance psychosis control against stiffness, restlessness, prolactin effects, or daytime drowsiness.
Doctors also look for patterns after dose changes. New pacing, inability to sit still, or worsening insomnia can indicate akathisia rather than simple anxiety. Fainting, palpitations, or unexplained seizures require a different level of urgency because they may point to cardiac or neurological complications.
The medicine works best when doses are taken consistently. Missed doses, abrupt stopping, alcohol use, and unsupervised dose changes can make it difficult to tell whether symptoms reflect the illness or the treatment pattern.
What customers often ask
Can older adults use Solian?
Older adults may use amisulpride when a psychiatrist judges that the expected benefit outweighs the risks. The French National Agency for Medicines and Health Products Safety (2021) and TGA (2023) recognise that age-related kidney decline can increase exposure, while older people may also experience more dizziness, falls, movement symptoms, confusion, and heart-rhythm problems. Treatment commonly starts cautiously, with attention to kidney function, blood pressure, mobility, and concurrent medicines. Antipsychotic treatment for dementia-related behavioural symptoms requires a separate risk assessment because serious adverse outcomes can occur. The TGA (2023) product information also supports careful review of cardiovascular and neurological risks.
How soon might the effect of Solian become noticeable?
Some people notice reduced agitation, improved sleep, or less distress within the early part of treatment, while hallucinations, delusions, and social withdrawal may take longer to improve. NICE guidance published in 2014 recommends reviewing response, adverse effects, adherence, and the person’s broader recovery goals rather than judging treatment from one early change. A lack of immediate improvement does not justify taking extra tablets. Persistent or worsening symptoms need a planned clinical review.
What happens after stopping Solian, and is tapering needed?
Abrupt stopping can lead to insomnia, nausea, sweating, anxiety, restlessness, and a return or worsening of psychotic symptoms. The Royal Australian and New Zealand College of Psychiatrists (2020) supports planned medication changes for schizophrenia, with the pace tailored to treatment duration, relapse history, and the person’s clinical state. Tapering is often considered, but the schedule is individual rather than automatic. Urgent help is needed if stopping is followed by severe agitation, confusion, suicidal thinking, or rapidly returning psychosis.
Can Solian tablets be split, crushed, or chewed?
A tablet should be swallowed with water unless the prescribed dosing plan specifically permits splitting. A score line may help divide some tablets, but it does not confirm that the halves contain identical amounts or that crushing is suitable. The Australian Medicines Handbook (2024) advises checking formulation-specific administration details because altering a tablet can affect dose accuracy and acceptability. Chewing may also make the medicine unpleasant and can complicate reliable administration.
How long does a Solian course last, and is long-term use acceptable?
Treatment duration depends on the diagnosis, relapse history, current symptoms, adverse effects, and recovery plan. Schizophrenia often requires maintenance treatment because stopping too early can increase relapse risk, while long-term treatment still needs regular review. The WHO (2016) guidance on psychosis care supports monitoring benefits and harms over time rather than using a fixed course length for every person. Long-term use may be appropriate when the treatment remains beneficial and monitoring shows that risks are manageable.
Which symptoms mean Solian should be stopped and medical help sought urgently?
Do not take another dose until urgent medical advice has been obtained for fainting, a fast or irregular heartbeat, seizure, severe allergic swelling, severe muscle stiffness with fever, marked confusion, or uncontrolled movements. The TGA identifies serious neurological and cardiac symptoms as requiring prompt assessment because they can signal uncommon but dangerous reactions. New suicidal thoughts, extreme agitation, or rapidly escalating hallucinations also require urgent psychiatric support. Stopping suddenly without assistance can worsen psychosis, so emergency clinicians should guide the next step.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Sources
- French National Agency for Medicines and Health Products Safety (2021). Solian (amisulpride) — Summary of Product Characteristics (RCP).
- Therapeutic Goods Administration (2023). Solian (amisulpride) — Product Information.
- World Health Organization (2016). Mental Health Gap Action Programme Intervention Guide: Version 2.0.
How Buyers Rate Solian
Based on 3 reviews
reported that Solian reduced voices and helped him return to a basic routine over about a month. He disliked reduced libido and occasional breast tenderness, which he initially kept private. After discussing the symptoms, his psychiatrist arranged monitoring and adjusted the treatment plan.
About a month 22 Oct 2026had used Solian as part of long-term schizophrenia management. He found taking the tablet at the same evening time easier than remembering irregular doses, although dizziness when standing made him cautious on stairs. His kidney function and other medicines were reviewed during follow-up.
Long-term 10 Nov 2026